Alirocumab: targeting PCSK9 to treat hypercholesterolemia.
E. Pecin, Z. Reiner
págs. 681-688
Pharmacological and clinical profile of lenvatinib (E-7080) in the treatment of advanced, radioiodine-refractory, differentiated thyroid cancer.
M Hegazi, A Azadi, D. Jain, R. O. Redman, César Augusto Pérez
págs. 689-694
Patiromer: a significant advance in the management of hyperkalemia.
David M. Paton
págs. 695-704
Triazole antifungals: a review.
L.R. Peyton, J. S. Gallagher, M. Hashemzadeh
págs. 705-718
Cumulative Index
págs. 719-751
© 2001-2026 Fundación Dialnet · Todos los derechos reservados
Coordinado por: